LZM008, a proposed tocilizumab biosimilar: Pharmacokinetics, safety, and immunogenicity profiles compared with ACTEMRA? in Chinese healthy male subjects
Frontiers in pharmacology(2023)
Key words
biosimilar,tocilizumab,pharmacokinetics,immunogenicity,safety
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined